AMB-001

N/A

Report date: 2023/08/09 11:39:06

Base Information

Drug NameAMB-001

Drug Alias NameAMB-001AMB001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAnti-Cell surface glycoprotein CD200 receptor 1

TargetsCell surface glycoprotein CD200 receptor 1

Therapy Area/IndicationsDermatitis, AtopicDementia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAimed Bio Inc

China Registration ClassN/A

Active CompaniesAimed Bio Inc

Inactive CompaniesN/A

Active IndicationsDermatitis, AtopicDementia

Inactive IndicationsN/A

ATC CodeN/A